Fischer Medical Ventures

828.95
-17.35
(-2.05%)
Market Cap
5,375.90 Cr
EPS
0.22
PE Ratio
-
Dividend Yield
0.00 %
Industry
Chemicals
52 Week High
919.00
52 Week Low
573.60
PB Ratio
17.30
Debt to Equity
0.03
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
939.00
#1 23,921.60
84.98
#1 15,112.00
-3.79
354
94.17
58.14
1,709.90
21,585.40
23.14
10,274.40
-22.71
#1 876
20.83
70.99
558.35
8,204.40
13.75
7,892.00
-20.68
566
62.31
59.54
429.25
6,786.90
-
4,346.07
-20.27
-169
-74.28
50.19
617.70
5,934.40
9.89
3,271.20
-6.51
624
20.34
53.15
828.95
#6 5,375.90
-
#9 110.70
#1 10,650.00
#7 1
#8 -50.00
42.86
103.60
4,697.30
29.86
1,133.69
9.90
160
-11.99
68.08
579.70
4,257.60
-
4,072.91
-14.52
-72
#1 119.05
43.68
3,911.75
3,902.00
44.27
556.98
0.60
89
78.74
67.61
55.23
3,327.90
#1 4.25
35.33
50.00
1
-200.00
91.38
Forecast
Actual
Growth Rate
Revenue Growth
10,650.00 %
Net Income Growth
5,135.34 %
Cash Flow Change
-165.49 %
ROE
-83.45 %
ROCE
-46.88 %
EBITDA Margin (Avg.)
29.78 %

Balance Sheet

Balance Sheet
2023
2024
2025
Total Assets
0
86
457
Fixed Assets
0
15
20
Current Assets
0
70
365
Capital Work in Progress
0
0
1
Investments
0
1
9
Other Assets
0
70
0
Total Liabilities
0
86
457
Current Liabilities
0
4
82
Non Current Liabilities
1
1
38
Total Equity
-0
81
307
Reserve & Surplus
-0
27
244
Share Capital
0
54
64

Cash Flow

Cash Flow
2024
Net Cash Flow
1
Investing Activities
-29
Operating Activities
-8
Financing Activities
37

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Jan 2024
Mar 2024
May 2024
Jun 2024
Sept 2024
Dec 2024
Feb 2025
Mar 2025
Apr 2025
Promoter
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
74.91 %
74.91 %
74.91 %
74.91 %
62.81 %
62.81 %
61.80 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
5.07 %
5.07 %
5.07 %
5.07 %
5.07 %
5.06 %
5.23 %
5.38 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
1.68 %
1.68 %
1.68 %
1.68 %
1.68 %
1.41 %
1.44 %
1.42 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
96.72 %
96.72 %
96.61 %
94.42 %
94.38 %
94.43 %
94.43 %
94.23 %
94.20 %
99.60 %
97.60 %
97.59 %
29.75 %
29.37 %
16.47 %
16.48 %
16.39 %
16.37 %
25.30 %
26.52 %
27.48 %
Others
3.28 %
3.28 %
3.39 %
5.58 %
5.62 %
5.57 %
5.57 %
5.77 %
5.80 %
0.40 %
2.40 %
2.41 %
70.25 %
63.88 %
1.87 %
1.86 %
1.94 %
1.96 %
5.41 %
3.99 %
3.93 %
No of Share Holders
9,046
9,043
9,085
9,109
9,093
9,121
9,121
9,064
9,060
9,085
9,104
9,038
9,065
8,976
8,975
9,285
9,502
9,688
9,865
10,180
10,182

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
28 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 May 2025 820.40 866.60
14 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Feb 2025 719.10 709.75
31 Jan 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
31 Jan 2025 708.50 710.85
13 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2024 645.90 625.50
17 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
17 Sept 2024 692.65 684.85
29 Mar 2024 CHANGE OF NAME Change Of Name
NA
29 Mar 2024 624.65 624.65
13 Jan 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
13 Jan 2024 195.80 252.95
28 Apr 2023 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
28 Apr 2023 88.40 103.70

Announcements

Closure of Trading Window8 days ago
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
Audited Results For The Year 31.03.2025May 30, 2025
Corporate Action-Board approves DividendMay 28, 2025
Board Meeting Outcome for Recommendation Of Dividend By The BoardMay 28, 2025
Audited Results For The Year 31.03.2025May 28, 2025
Board Meeting Intimation for Consideration And Approval Of Audited Financial Results For The Year And Quarter Ended 31.03.2025 And To Recommend Final Dividend If Any And To Transact Other General Matters As Stated In The AgendaMay 22, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 16, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMay 05, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 30, 2025
Announcement Under Regulation 30Apr 23, 2025
Announcement Under Regulation 30 - Intimation Of Receipt Of Central Government ApprovalApr 23, 2025
Announcement Under Regulation 30Apr 21, 2025
Announcement Under Regulation 30Apr 21, 2025
General UpdateApr 10, 2025
Update On Allotment Of ISINApr 09, 2025
Announcement under Regulation 30 (LODR)-AllotmentApr 09, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2025
Intimation About Investment By Material SubsidiaryApr 07, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 04, 2025
Closure of Trading WindowApr 04, 2025
Postal Ballot Notice IntimationApr 04, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 31, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorMar 27, 2025
Reconstitution Of CommitteesMar 27, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorMar 26, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On 26Th March 2025Mar 26, 2025
Update By Material SubsidiaryMar 25, 2025
Board Meeting Intimation for Change In Independent Director And Other Related And General Corporate PurposeMar 24, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 07, 2025
Announcement under Regulation 30 (LODR)-AllotmentMar 04, 2025
Announcement under Regulation 30 (LODR)-Change in Registered Office AddressMar 04, 2025
Integrated Filing (Financial)Mar 03, 2025
Announcement under Regulation 30 (LODR)-AllotmentMar 03, 2025
Integrated Filing (Financial)Mar 03, 2025
Announcement Relating To Proposed Investment Of Funds In Wholly Owned SubsidiaryFeb 26, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 25, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 24, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 21, 2025
Update On Receipt Of Disclosure Under Regulation 29(2) Of SEBI (SAST) 2015Feb 19, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 18, 2025
Board Meeting Outcome for Allotment Of Equity Shares And WarrantsFeb 18, 2025
Announcement Under Regulation 30 - Incorporation Of Subsidiary CompanyFeb 15, 2025
Board Meeting Outcome for RESULTS - FINANCIAL RESULTS - 31.12.2024Feb 14, 2025
Results - Financial Results For 31/12/2024Feb 14, 2025
Update From Material SubsidiaryFeb 13, 2025
Announcement Under Regulation 30 - Update On Re- Constitution Of Audit CommitteeFeb 12, 2025
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ended 31.12.2024Feb 07, 2025
Intimation Of Supply Of 10 Nos. Of 1.5T Whole Body MRI Machines To Atrium DiagnosticsFeb 05, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportFeb 02, 2025

Technical Indicators

RSI(14)
Neutral
42.86
ATR(14)
Less Volatile
35.11
STOCH(9,6)
Neutral
54.67
STOCH RSI(14)
Oversold
9.10
MACD(12,26)
Bearish
-2.74
ADX(14)
Weak Trend
13.97
UO(9)
Bearish
46.39
ROC(12)
Downtrend And Accelerating
-2.49
WillR(14)
Oversold
-91.80